What does other nonoperating income expenses mean?

This metric captures miscellaneous financial gains or losses that are not directly related to the company's core clinical development or commercial operations. It includes items such as foreign currency transaction adjustments, minor asset disposals, or other incidental non-recurring financial activities. Monitoring this helps investors isolate the impact of peripheral financial events from the company's primary operating performance.

Upstream Bio, Inc. UPB Other Nonoperating Income Expenses

Other Nonoperating Income Expenses at other companies

Vor BiopharmaVOR

$2K—

MoonLake ImmunotherapeuticsMLTX

$3.21M-54.8%

Cricut, Inc.CRCT

$55K+2,650%

Sionna Therapeutics, Inc. Common StockSION

$0-100%

Strattec SecuritySTRT

$205K-69.8%

American Battery Technology CompanyABAT

$233.74K+437%

Other financials

Income statement

See full

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

See full

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

See full

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

See full

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

See full

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

See full

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept upb:OtherNonoperatingIncomeExpenses.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s other nonoperating income expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Upstream Bio, Inc.'s other nonoperating income expenses?: Upstream Bio, Inc. (UPB) reported other nonoperating income expenses of -$30K in Q1 2026.
What does other nonoperating income expenses mean?: This metric captures miscellaneous financial gains or losses that are not directly related to the company's core clinical development or commercial operations. It includes items such as foreign currency transaction adjustments, minor asset disposals, or other incidental non-recurring financial activities. Monitoring this helps investors isolate the impact of peripheral financial events from the company's primary operating performance.